Hem › Kronisk myeloisk leukemi › Texas
Kliniska studier för Kronisk myeloisk leukemi i Texas
18 studier för Kronisk myeloisk leukemi söker deltagare vid platser i Texas.
Städer i Texas
Officiell studietext (engelska)
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- The Don and Sybil Harrington Cancer Center, Amarillo
- UT MD Anderson Cancer Center, Houston
- Audie L Murphy VA Hospital, San Antonio
RekryterarObservationsstudieFriska volontärer välkomna
Ålder 40 till 75 · Alla kön · Uppdaterad 2 okt. 2026 · NCT05334069Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
- Texas Children's Hospital, Houston
RekryterarObservationsstudie
Ålder 0 till 38 · Alla kön · Uppdaterad 1 okt. 2026 · NCT06131801Phase II Study Assessing the Efficacy and Toxicity of Olverembatinib Monotherapy in Patients With Chronic Myeloid Leukemia in Chronic Phase After Failing One Prior Therapy With a Second Generation Tyrosine Kinase Inhibitor or Asciminib
- MD Anderson Cancer Center, Houston
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 1 okt. 2026 · NCT06817720Phase II Study Assessing the Safety and Efficacy of Dasatinib in Combination With Ropeginterferon in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase
- The University of Texas M. D. Anderson Cancer Center, Houston
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT07269470Phase II Study Assessing Efficacy and Safety of Asciminib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase.
- MD Anderson Cancer Center, Houston
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT06236724Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
- M D Anderson Cancer Center, Houston
RekryterarFas 1
Ålder 1 och äldre · Alla kön · Uppdaterad 18 sep. 2026 · NCT03630991Ponatinib Hydrochloride as Second Line Therapy in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase Resistant or Intolerant to Imatinib Mesylate, Dasatinib, or Nilotinib
- M D Anderson Cancer Center, Houston
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 16 sep. 2026 · NCT01746836Study of Olverembatinib (HQP1351) in Patients With CML-CP
- Ascentage Investigative Site #1051, Amarillo
- Ascentage Investigative Site #1036, Austin
- Ascentage Investigative Site #1501, Houston
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 15 sep. 2026 · NCT06423911A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Medical City Dallas, Dallas
- Children's Medical Center Dallas, Dallas
- Zachary & Elizabeth Fisher Bone Marrow Transplant Program (Brooke Army Medical Center), Fort Sam Houston
- och 5 fler
RekryterarObservationsstudie
Alla åldrar · Alla kön · Uppdaterad 6 juli 2026 · NCT01351545Asciminib Roll-over Study
- Texas Oncology, Dallas
- Uni Of TX MD Anderson Cancer Cntr, Houston
RekryterarFas 4
Ålder 7 till 100 · Alla kön · Uppdaterad 6 juli 2026 · NCT04877522Cladribine, Idarubicin, Cytarabine, and Venetoclax in Treating Patients With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, or Blastic Phase Chronic Myeloid Leukemia
- M D Anderson Cancer Center, Houston
RekryterarFas 2
Ålder 18 till 65 · Alla kön · Uppdaterad 20 maj 2026 · NCT02115295Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial
- University of Texas MD Anderson Cancer Center, Houston
RekryterarObservationsstudie
Alla åldrar · Alla kön · Uppdaterad 16 apr. 2026 · NCT00816114A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia
- The University of Texas MD Anderson Cancer Center, Houston
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 1 apr. 2026 · NCT05304377A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
- MD Anderson, Houston
RekryterarFas 2
Ålder 18 till 66 · Alla kön · Uppdaterad 17 mars 2026 · NCT06859424A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias
- MD Anderson Cancer Center, Houston
RekryterarFas 1
Ålder 12 och äldre · Alla kön · Uppdaterad 16 mars 2026 · NCT06994676A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)
- The University of Texas M.D. Anderson Cancer Center, Houston
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 12 jan. 2026 · NCT06163430Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL
- University of Texas MD Anderson Cancer Center, Houston
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 5 nov. 2025 · NCT04260022TGRX-678 US Phase I for Subjects with Refractory or Advanced Chronic Myelogenous Leukemia
- The University of Texas MD Anderson Cancer Center, Houston
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 21 feb. 2025 · NCT06088888Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.